These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 25326645

  • 1. Macrophage polarization in pancreatic carcinoma: role of heparanase enzyme.
    Hermano E, Meirovitz A, Meir K, Nussbaum G, Appelbaum L, Peretz T, Elkin M.
    J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25326645
    [Abstract] [Full Text] [Related]

  • 2. Tumor-neuroglia interaction promotes pancreatic cancer metastasis.
    Su D, Guo X, Huang L, Ye H, Li Z, Lin L, Chen R, Zhou Q.
    Theranostics; 2020 Dec; 10(11):5029-5047. PubMed ID: 32308766
    [Abstract] [Full Text] [Related]

  • 3. Tumor-driven like macrophages induced by conditioned media from pancreatic ductal adenocarcinoma promote tumor metastasis via secreting IL-8.
    Chen SJ, Lian GD, Li JJ, Zhang QB, Zeng LJ, Yang KG, Huang CM, Li YQ, Chen YT, Huang KH.
    Cancer Med; 2018 Nov; 7(11):5679-5690. PubMed ID: 30311406
    [Abstract] [Full Text] [Related]

  • 4. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
    Yin Z, Ma T, Huang B, Lin L, Zhou Y, Yan J, Zou Y, Chen S.
    J Exp Clin Cancer Res; 2019 Jul 15; 38(1):310. PubMed ID: 31307515
    [Abstract] [Full Text] [Related]

  • 5. PG545, an angiogenesis and heparanase inhibitor, reduces primary tumor growth and metastasis in experimental pancreatic cancer.
    Ostapoff KT, Awasthi N, Cenik BK, Hinz S, Dredge K, Schwarz RE, Brekken RA.
    Mol Cancer Ther; 2013 Jul 15; 12(7):1190-201. PubMed ID: 23696215
    [Abstract] [Full Text] [Related]

  • 6. Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages.
    Incio J, Suboj P, Chin SM, Vardam-Kaur T, Liu H, Hato T, Babykutty S, Chen I, Deshpande V, Jain RK, Fukumura D.
    PLoS One; 2015 Jul 15; 10(12):e0141392. PubMed ID: 26641266
    [Abstract] [Full Text] [Related]

  • 7. Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells.
    Nagathihalli NS, Castellanos JA, VanSaun MN, Dai X, Ambrose M, Guo Q, Xiong Y, Merchant NB.
    Oncotarget; 2016 Oct 04; 7(40):65982-65992. PubMed ID: 27602757
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-454 regulates stromal cell derived factor-1 in the control of the growth of pancreatic ductal adenocarcinoma.
    Fan Y, Xu LL, Shi CY, Wei W, Wang DS, Cai DF.
    Sci Rep; 2016 Mar 15; 6():22793. PubMed ID: 26976451
    [Abstract] [Full Text] [Related]

  • 9. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
    Wu YS, Chung I, Wong WF, Masamune A, Sim MS, Looi CY.
    Biochim Biophys Acta Gen Subj; 2017 Feb 15; 1861(2):296-306. PubMed ID: 27750041
    [Abstract] [Full Text] [Related]

  • 10. IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcinoma through the STAT3 pathway.
    Sun L, Zhang X, Song Q, Liu L, Forbes E, Tian W, Zhang Z, Kang Y, Wang H, Fleming JB, Pasche BC, Zhang W.
    Cancer Lett; 2021 Mar 01; 500():132-146. PubMed ID: 33309859
    [Abstract] [Full Text] [Related]

  • 11. KLHDC7B-DT aggravates pancreatic ductal adenocarcinoma development via inducing cross-talk between cancer cells and macrophages.
    Li MX, Wang HY, Yuan CH, Ma ZL, Jiang B, Li L, Zhang L, Xiu DR.
    Clin Sci (Lond); 2021 Feb 26; 135(4):629-649. PubMed ID: 33538300
    [Abstract] [Full Text] [Related]

  • 12. Circular RNA ciRS-7 promotes the proliferation and metastasis of pancreatic cancer by regulating miR-7-mediated EGFR/STAT3 signaling pathway.
    Liu L, Liu FB, Huang M, Xie K, Xie QS, Liu CH, Shen MJ, Huang Q.
    Hepatobiliary Pancreat Dis Int; 2019 Dec 26; 18(6):580-586. PubMed ID: 30898507
    [Abstract] [Full Text] [Related]

  • 13. Duffy antigen receptor for chemokines (DARC) expressing in cancer cells inhibits tumor progression by suppressing CXCR2 signaling in human pancreatic ductal adenocarcinoma.
    Maeda S, Kuboki S, Nojima H, Shimizu H, Yoshitomi H, Furukawa K, Miyazaki M, Ohtsuka M.
    Cytokine; 2017 Jul 26; 95():12-21. PubMed ID: 28214673
    [Abstract] [Full Text] [Related]

  • 14. Tumor-associated macrophages drive glycolysis through the IL-8/STAT3/GLUT3 signaling pathway in pancreatic cancer progression.
    Zhong Z, Yang K, Li Y, Zhou S, Yao H, Zhao Y, Huang Y, Zou J, Li Y, Jiajia Li, Lian G, Huang K, Chen S.
    Cancer Lett; 2024 Apr 28; 588():216784. PubMed ID: 38458594
    [Abstract] [Full Text] [Related]

  • 15. Cancer-associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma.
    Zhang A, Qian Y, Ye Z, Chen H, Xie H, Zhou L, Shen Y, Zheng S.
    Cancer Med; 2017 Feb 28; 6(2):463-470. PubMed ID: 28097809
    [Abstract] [Full Text] [Related]

  • 16. Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling.
    Zhao W, Ajani JA, Sushovan G, Ochi N, Hwang R, Hafley M, Johnson RL, Bresalier RS, Logsdon CD, Zhang Z, Song S.
    Gastroenterology; 2018 Apr 28; 154(5):1524-1537.e6. PubMed ID: 29274868
    [Abstract] [Full Text] [Related]

  • 17. Heparanase Accelerates Obesity-Associated Breast Cancer Progression.
    Hermano E, Goldberg R, Rubinstein AM, Sonnenblick A, Maly B, Nahmias D, Li JP, Bakker MAH, van der Vlag J, Vlodavsky I, Peretz T, Elkin M.
    Cancer Res; 2019 Oct 15; 79(20):5342-5354. PubMed ID: 31481501
    [Abstract] [Full Text] [Related]

  • 18. Hypoxia Inducible Factor 1 (HIF-1) Recruits Macrophage to Activate Pancreatic Stellate Cells in Pancreatic Ductal Adenocarcinoma.
    Li N, Li Y, Li Z, Huang C, Yang Y, Lang M, Cao J, Jiang W, Xu Y, Dong J, Ren H.
    Int J Mol Sci; 2016 Jun 03; 17(6):. PubMed ID: 27271610
    [Abstract] [Full Text] [Related]

  • 19. SMAD4 loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells.
    Chen YW, Hsiao PJ, Weng CC, Kuo KK, Kuo TL, Wu DC, Hung WC, Cheng KH.
    BMC Cancer; 2014 Mar 14; 14():181. PubMed ID: 24625091
    [Abstract] [Full Text] [Related]

  • 20. PRMT1 promotes pancreatic cancer growth and predicts poor prognosis.
    Song C, Chen T, He L, Ma N, Li JA, Rong YF, Fang Y, Liu M, Xie D, Lou W.
    Cell Oncol (Dordr); 2020 Feb 14; 43(1):51-62. PubMed ID: 31520395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.